Theresa Bruce

Biography

Theresa Bruce is the Vice President of Clinical Operations at Veristat. In this role, Theresa provides leadership and strategic oversight to Veristat’s clinical operations team including the project management and clinical monitoring groups. She has more than 24 years of clinical research experience in both the pharmaceutical and CRO industries. She is passionate about drug development having spent the last 16 years providing leadership and project management support for numerous complex trials. Prior to joining Veristat, Theresa founded and managed a UK-based oncology-focused CRO, Spero Oncology.  Previously, she was the COO of Nexus Oncology.  And, following the acquisition of Nexus by Ockham Oncology, she remained as Vice-President, Global Operations. Originally trained as a nurse, she worked as a Research Sister in a large teaching hospital in Glasgow and subsequently completed her MBA in the city. Theresa Bruce is the Vice President of Clinical Operations at Veristat. In this role, Theresa provides leadership and strategic oversight to Veristat’s clinical operations team including the project management and clinical monitoring groups. She has more than 24 years of clinical research experience in both the pharmaceutical and CRO industries. She is passionate about drug development having spent the last 16 years providing leadership and project management support for numerous complex trials. Prior to joining Veristat, Theresa founded and managed a UK-based oncology-focused CRO, Spero Oncology.  Previously, she was the COO of Nexus Oncology.  And, following the acquisition of Nexus by Ockham Oncology, she remained as Vice-President, Global Operations. Originally trained as a nurse, she worked as a Research Sister in a large teaching hospital in Glasgow and subsequently completed her MBA in the city.

Research Interest

pharmaceutical and CRO industries.